Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.07%49.47B | 1.24%10.98B | 2.37%46.64B | -0.65%11.27B | 1.83%13.31B | 1.72%11.22B | 7.14%10.84B | 5.65%45.56B | 6.97%11.35B | 11.04%13.07B |
| Cost of revenue | 6.25%39.68B | 1.60%8.86B | 1.48%37.34B | -1.28%9.02B | 0.75%10.58B | 0.69%9.01B | 6.34%8.72B | 5.80%36.8B | 6.82%9.14B | 11.26%10.5B |
| Gross profit | 5.34%9.79B | -0.24%2.11B | 6.09%9.29B | 1.97%2.25B | 6.23%2.72B | 6.20%2.2B | 10.54%2.12B | 5.03%8.76B | 7.60%2.2B | 10.16%2.56B |
| Operating expense | 5.45%7.39B | 1.53%1.74B | 6.53%7.01B | 6.41%1.85B | 7.19%1.75B | 4.96%1.7B | 7.58%1.71B | 5.01%6.58B | 8.78%1.74B | 0.70%1.63B |
| Operating profit | 5.02%2.4B | -7.68%375.24M | 4.78%2.28B | -14.58%398.47M | 4.56%975.76M | 10.65%500.51M | 25.02%406.48M | 5.11%2.18B | 3.40%466.49M | 31.78%933.25M |
| Net non-operating interest income (expenses) | 80.00%-78K | 97.62%-3K | 49.74%-390K | 89.09%-24K | 26.09%-136K | 37.35%-104K | 38.83%-126K | -23.76%-776K | -4.76%-220K | 7.54%-184K |
| Non-operating interest income | 202.71%1.9M | 88.43%228K | 10.76%628K | 17.01%227K | -0.80%124K | 5.41%156K | 21.00%121K | -19.69%567K | 5.43%194K | 12.61%125K |
| Non-operating interest expense | 94.40%1.98M | -6.48%231K | -24.20%1.02M | -39.37%251K | -15.86%260K | -17.20%260K | -19.28%247K | 0.75%1.34M | 5.08%414K | -0.32%309K |
| Net investment income | 12.04%95.01M | 17.88%7.64M | 4.17%84.8M | 2.63%35.24M | 7.69%8.24M | 20.82%34.85M | -38.79%6.48M | 36.23%81.41M | 36.79%34.33M | 55.93%7.65M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 6,268.14%115.96M | -20,372.37%-31.12M | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -613.58%-42.55M | 0 | -108.07%-5.96M | -133.56%-148K | 103.31%1.61M | -139.58%-48.18M | 13,004.82%40.76M | 17,083.26%73.89M | 658.23%441K | -814.15%-48.58M |
| Less:Other special charges | 55.81%9.29M | ---- | 104.87%5.96M | 133.56%148K | -6,332.00%-1.61M | 139.58%48.18M | -13,004.82%-40.76M | -28,386.28%-122.49M | -658.23%-441K | -100.47%-25K |
| Less:Write off | --33.26M | ---- | --0 | --0 | ---- | ---- | ---- | --48.6M | --0 | ---- |
| Other non-operating income (expenses) | -9.28%415.89M | -6.33%97.31M | 8.80%458.45M | -7.07%105.15M | 3.03%104.55M | 40.05%144.87M | 0.57%103.89M | 4.26%421.37M | 4.84%113.15M | 3.67%101.48M |
| Income before tax | 1.63%2.86B | -13.86%480.19M | -1.78%2.82B | -7.62%538.68M | -4.44%1.09B | -10.51%631.94M | 26.95%557.47M | 13.25%2.87B | -0.12%583.08M | 41.93%1.14B |
| Income tax | 0.58%946.79M | -16.00%165.27M | 22.66%941.38M | 85.65%159.05M | -1.20%368.45M | 40.31%217.13M | 27.65%196.75M | -14.57%767.5M | -63.17%85.67M | 35.83%372.94M |
| Net income | 2.16%1.92B | -12.70%314.91M | -10.70%1.88B | -23.68%379.62M | -6.02%721.56M | -24.77%414.81M | 26.58%360.72M | 28.54%2.1B | 41.65%497.4M | 45.09%767.75M |
| Net income continuous operations | 2.16%1.92B | -12.70%314.91M | -10.70%1.88B | -23.68%379.62M | -6.02%721.57M | -24.77%414.81M | 26.58%360.72M | 28.54%2.1B | 41.65%497.41M | 45.09%767.75M |
| Noncontrolling interests | 0 | 0 | 0 | |||||||
| Net income attributable to the company | 2.16%1.92B | -12.70%314.91M | -10.70%1.88B | -23.68%379.62M | -6.02%721.56M | -24.77%414.81M | 26.58%360.72M | 28.54%2.1B | 41.65%497.4M | 45.09%767.75M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 2.16%1.92B | -12.70%314.91M | -10.70%1.88B | -23.68%379.62M | -6.02%721.56M | -24.77%414.81M | 26.58%360.72M | 28.54%2.1B | 41.65%497.4M | 45.09%767.75M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 5.45%98.18 | -12.41%15.675 | -10.69%93.11 | -23.67%18.835 | -6.03%35.795 | -24.75%20.585 | 26.56%17.895 | 29.19%104.26 | 41.53%24.675 | 45.35%38.09 |
| Diluted earnings per share | 5.45%98.18 | -12.41%15.675 | -10.69%93.11 | -23.67%18.8338 | -6.02%35.795 | -24.77%20.5795 | 26.56%17.895 | 29.19%104.26 | 41.64%24.675 | 45.35%38.0893 |
| Dividend per share | 27.14%44.5 | 0 | 7.69%35 | 0.00%17.5 | 0 | 16.67%17.5 | 0 | 8.33%32.5 | 16.67%17.5 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |